CYTOKINETICS, INCORPORATED (CYTK) Free cash flow 2016–2025
CYTOKINETICS, INCORPORATED (CYTK) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$534.8MFY2025 · since FY2016: $35.4M → -$534.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$534.8M | -33.8% |
| FY2024 | -$399.8M | +3.8% |
| FY2023 | -$415.7M | -33.7% |
| FY2022 | -$310.9M | -62.4% |
| FY2021 | -$191.4M | -8975.1% |
| FY2020 | -$2.1M | +97.7% |
| FY2019 | -$93.5M | +8.4% |
| FY2018 | -$102.1M | +2.4% |
| FY2017 | -$104.6M | -395.7% |
| FY2016 | $35.4M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice